Literature DB >> 1379395

Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1.

J M Moulds1, J J Moulds, M Brown, J P Atkinson.   

Abstract

The Knops, McCoy, Swain-Langley and York antigens have recently been identified as being on complement receptor type 1 (CR1, CD35, C3b/C4b receptor). We examined the relationship between CR1 expression and the reactivity of the CR1-related blood group antigens with their specific antibodies. RBC from donors of selected phenotypes were tested by hemagglutination using two monoclonal antibodies to CR1, as well as anti-Kna, -McCa, -S1a, -'Kn/McC' and -Yka. Monoclonal antibodies 3D9 and E11 required approximately 250 and approximately 400 CR1/RBC to obtain a positive reaction. Agglutination of antigen-positive cells by human polyclonal antisera was related to the CR1/RBC: thus, cells expressing 20-100 CR1/RBC were negative and included the previously designated null phenotypes for this collection, 100-150 were weak or negative, and greater than 200 were usually positive. One RBC sample carried Yka on the 190,000 dalton (A or F allele), but not the 220,000 dalton (B or S allele) variant of CR1, and gave inconsistent reactions with Yka antisera. These data provide an explanation for certain of the serologic characteristics of the CR1-related blood group antigen system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379395     DOI: 10.1111/j.1423-0410.1992.tb01204.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  13 in total

Review 1.  Development of complement therapeutics for inhibition of immune-mediated red cell destruction.

Authors:  Karina Yazdanbakhsh
Journal:  Transfusion       Date:  2005-08       Impact factor: 3.157

2.  Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3' untranslated regions of the CR1 gene.

Authors:  I A Cockburn; J A Rowe
Journal:  Int J Immunogenet       Date:  2006-02       Impact factor: 1.466

3.  Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients.

Authors:  S Sadallah; C Hess; M Trendelenburg; C Vedeler; M Lopez-Trascasa; J A Schifferli
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 4.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

5.  When recombinant proteins can replace rare red cells in immunohematology workups.

Authors:  Willy A Flegel; Kshitij Srivastava
Journal:  Transfusion       Date:  2021-05-31       Impact factor: 3.337

6.  No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.

Authors:  O V Swann; E M Harrison; D H Opi; E Nyatichi; A Macharia; S Uyoga; T N Williams; J A Rowe
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

7.  High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment.

Authors:  Aymric Kisserli; Thierry Tabary; Jacques Henri Max Cohen; Valérie Duret; Rachid Mahmoudi
Journal:  J Vis Exp       Date:  2017-07-18       Impact factor: 1.355

8.  Identification of the Kna/Knb polymorphism and a method for Knops genotyping.

Authors:  J M Moulds; B J Thomas; O Doumbo; D A Diallo; K E Lyke; C V Plowe; J A Rowe; D J Birmingham
Journal:  Transfusion       Date:  2004-02       Impact factor: 3.157

9.  Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali.

Authors:  Bolaji N Thomas; Dapa A Diallo; Ghislain T Noumsi; Joann M Moulds
Journal:  Biomark Insights       Date:  2012-07-03

10.  Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Authors:  D H Opi; S Uyoga; E N Orori; T N Williams; J A Rowe
Journal:  Genes Immun       Date:  2016-02-04       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.